BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24355766)

  • 21. Thiamine Responsive Megaloblastic Anaemia, Diabetes Mellitus and Sensorineural Hearing Loss in a Child.
    Khurshid A; Fatimah S; Altaf C; Malik HS; Sajjad Z; Khadim MT
    J Coll Physicians Surg Pak; 2018 Sep; 28(9):S169-S171. PubMed ID: 30173687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRMA syndrome with a severe phenotype, cerebral infarction, and novel compound heterozygous SLC19A2 mutation: a case report.
    Li X; Cheng Q; Ding Y; Li Q; Yao R; Wang J; Wang X
    BMC Pediatr; 2019 Jul; 19(1):233. PubMed ID: 31296181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare case with megaloblastic anaemia.
    Saleem M; Shah SS; Mehmood T
    J Ayub Med Coll Abbottabad; 2014; 26(1):104-5. PubMed ID: 25358233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
    Raz T; Labay V; Baron D; Szargel R; Anbinder Y; Barrett T; Rabl W; Viana MB; Mandel H; Baruchel A; Cayuela JM; Cohen N
    Hum Mutat; 2000; 16(1):37-42. PubMed ID: 10874303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity.
    Abboud MR; Alexander D; Najjar SS
    J Pediatr; 1985 Oct; 107(4):537-41. PubMed ID: 4045602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
    Onal H; Bariş S; Ozdil M; Yeşil G; Altun G; Ozyilmaz I; Aydin A; Celkan T
    Turk J Pediatr; 2009; 51(3):301-4. PubMed ID: 19817279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
    Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
    Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Mutation of SLC19A2 in a Chinese Zhuang Ethnic Family with Thiamine-Responsive Megaloblastic Anemia.
    Xian X; Liao L; Shu W; Li H; Qin Y; Yan J; Luo J; Lin FQ
    Cell Physiol Biochem; 2018; 47(5):1989-1997. PubMed ID: 29969779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thiamine responsive megaloblastic anemia.
    Mathews L; Narayanadas K; Sunil G
    Indian Pediatr; 2009 Feb; 46(2):172-4. PubMed ID: 19242038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
    Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
    Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thiamine-responsive megaloblastic anemia or Rogers syndrome: A literature review].
    Lu H; Lu H; Vaucher J; Tran C; Vollenweider P; Castioni J
    Rev Med Interne; 2019 Jan; 40(1):20-27. PubMed ID: 30031565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiamine responsive megaloblastic anemia in three Indian children.
    Raju K N Gowda V; Shivananda GM; Sankhyan N
    Indian J Pediatr; 2011 Jul; 78(7):888-9. PubMed ID: 21340725
    [No Abstract]   [Full Text] [Related]  

  • 33. Thiamine-responsive megaloblastic anemia syndrome.
    Bay A; Keskin M; Hizli S; Uygun H; Dai A; Gumruk F
    Int J Hematol; 2010 Oct; 92(3):524-6. PubMed ID: 20835854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiamine-responsive megaloblastic anemia syndrome: long term follow-up.
    Borgna-Pignatti C; Azzalli M; Pedretti S
    J Pediatr; 2009 Aug; 155(2):295-7. PubMed ID: 19619756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
    Shaw-Smith C; Flanagan SE; Patch AM; Grulich-Henn J; Habeb AM; Hussain K; Pomahacova R; Matyka K; Abdullah M; Hattersley AT; Ellard S
    Pediatr Diabetes; 2012 Jun; 13(4):314-21. PubMed ID: 22369132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
    Diaz GA; Banikazemi M; Oishi K; Desnick RJ; Gelb BD
    Nat Genet; 1999 Jul; 22(3):309-12. PubMed ID: 10391223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiamine responsive megaloblastic anemia: the puzzling phenotype.
    Beshlawi I; Al Zadjali S; Bashir W; Elshinawy M; Alrawas A; Wali Y
    Pediatr Blood Cancer; 2014 Mar; 61(3):528-31. PubMed ID: 24249281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
    Wu S; Yuan Z; Sun Z; Yao F; Sui R
    Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiamine-responsive megaloblastic anaemia.
    Veetil VM; Pachat D; Nikitha K; Kutty JM
    Natl Med J India; 2023; 36(5):314-315. PubMed ID: 38759983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
    Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.